Long-Term Efficacy and Safety of Copanlisib in Multiply Relapsed or Refractory Patients with Marginal Zone Lymphoma

被引：1

作者：

Dreyling, Martin ^{[1
]}

Panayiotidis, Panayiotis ^{[2
]}

Follows, George A. ^{[3
]}

Mollica, Luigina ^{[4
]}

Nagler, Arnon ^{[5
]}

Ozcan, Muhit ^{[6
]}

Santoro, Armando ^{[7
]}

Stevens, Don ^{[8
]}

Trevarthen, David ^{[9
]}

Hiemeyer, Florian ^{[10
]}

Liu, Li ^{[11
]}

Garcia-Vargas, Jose ^{[11
]}

Childs, Barrett H. ^{[11
]}

Zinzani, Pier Luigi ^{[12
]}

机构：

[1] Univ Hosp LMU, Dept Med 3, Munich, Germany

[2] Natl & Kapodistrian Univ Athens, Sch Med, Athens, Greece

[3] Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England

[4] Maisonneuve Rosemont Hosp Res Ctr, Montreal, PQ, Canada

[5] Tel Aviv Univ, Chaim Sheba Med Ctr, Tel Hashomer, Israel

[6] Ankara Univ, Ankara, Turkey

[7] Humanitas Clin & Res Ctr, Rozzano, Italy

[8] Norton Canc Inst, Louisville, KY USA

[9] Comprehens Canc Care & Res Inst Colorado, Englewood, CO USA

[10] Bayer AG, Div Pharmaceut, Berlin, Germany

[11] Bayer HealthCare Pharmaceut Inc, Whippany, NJ USA

[12] Univ Bologna, Inst Hematol Seragnoli, Bologna, Italy

来源：

BLOOD | 2019年 / 134卷

关键词：

D O I：

10.1182/blood-2019-121932

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1531

引用

页数：5

共 50 条

[1] Efficacy and safety of copanlisib in patients with relapsed or refractory marginal zone lymphoma
Panayiotidis, Panayiotis
Follows, George A.
Mollica, Luigina
Nagler, Arnon
Ozcan, Muhit
Santoro, Armando
Stevens, Don
Trevarthen, David
Hiemeyer, Florian
Garcia-Vargas, Jose
Childs, Barrett H.
Zinzani, Pier Luigi
Dreyling, Martin
BLOOD ADVANCES, 2021, 5 (03) : 823 - 828
[2] Long-Term Efficacy and Safety from the Copanlisib CHRONOS-1 Study in Patients with Relapsed or Refractory Indolent B-Cell Lymphoma
Dreyling, Martin
Santoro, Armando
Mollica, Luigina
Leppa, Sirpa
Follows, George A.
Lenz, Georg
Kim, Won Seog
Nagler, Arnon
Panayiotidis, Panayiotis
Demeter, Judit
Ozcan, Muhit
Kosinova, Marina
Bouabdallah, Krimo
Morschhauser, Franck
Stevens, Don
Trevarthen, David
Rodrigues, Liana
Hiemeyer, Florian
Wang, MingLu
Garcia-Vargas, Jose
Childs, Barrett H.
Zinzani, Pier Luigi
BLOOD, 2018, 132
[3] Efficacy of Copanlisib Monotherapy in Patients with Relapsed or Refractory Marginal Zone Lymphoma: Subset Analysis from the CHRONOS-1 Trial
Dreyling, Martin
Panayiotidis, Panayiotis
Egyed, Miklos
Follows, George
Mollica, Luigina
Nagler, Arnon
Ozcan, Muhit
Santoro, Armando
Ishida, Tatiane
Lu, Cindy
Hiemeyer, Florian
Garcia-Vargas, Jose
Childs, Barrett H.
Zinzani, Pier Luigi
BLOOD, 2017, 130
[4] Efficacy of Copanlisib Monotherapy in Patients With Relapsed or Refractory Marginal Zone Lymphoma: Subset Analysis From the CHRONOS-1 Trial
Martin, Peter
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (04) : 10 - 11
[5] SAFETY AND EFFICACY OF ZANUBRUTINIB IN PATIENTS WITH RELAPSED/REFRACTORY MARGINAL ZONE LYMPHOMA (MAGNOLIA PHASE 2 STUDY)
Tedeschi, A.
Trotman, J.
Zinzani, P.
Cavallo, F.
Marasca, R.
Liberati, A.
Linton, K.
Mckay, P.
Hu, B.
Coleman, M.
Ardeshna, K.
Bijou, F.
Marcus, R.
Portell, C.
Thieblemont, C.
Bachy, E.
Costello, R.
Iyengar, S.
Mocikova, H.
Co, M.
Li, X.
Zhou, W.
Cappellini, M.
Tankersley, C.
Huang, J.
Opat, S.
HAEMATOLOGICA, 2021, 106 (10) : 35 - 35
[6] Long-Term Efficacy and Safety of Zanubrutinib in Patients with Relapsed/Refractory (R/R) Marginal Zone Lymphoma (MZL): Final Analysis of the Magnolia (BGB-3111-214) Trial
Opat, Stephen
Tedeschi, Alessandra
Hu, Bei
Linton, Kim M.
McKay, Pamela
Chan, Henry
Jin, Jie
Sun, Mingyuan
Sobieraj-Teague, Magdalena
Zinzani, Pier Luigi
Browett, Peter J.
Ke, Xiaoyan
Portell, Craig A.
Thieblemont, Catherine
Ardeshna, Kirit
Bijou, Fontanet
Walker, Patricia
Hawkes, Eliza
Ho, Shir-Jing
Zhou, Keshu
Liang, Zhiyu
Xu, Jianfeng
Tankersley, Chris
Delarue, Richard
Co, Melannie
Trotman, Judith
BLOOD, 2022, 140
[7] Safety and efficacy of zanubrutinib in relapsed/refractory marginal zone lymphoma: final analysis of the MAGNOLIA study
Opat, Stephen
Tedeschi, Alessandra
Hu, Bei
Linton, Kim M.
Mckay, Pamela
Leitch, Sophie
Coleman, Morton
Zinzani, Pier Luigi
Jin, Jie
Sun, Mingyuan
Sobieraj-Teague, Magdalena
Browett, Peter
Ke, Xiaoyan
Thieblemont, Catherine
Ardeshna, Kirit
Bijou, Fontanet
Walker, Patricia
Hawkes, Eliza A.
Ho, Shir-Jing
Zhou, Keshu
Liang, Zhiyu
Xu, Jianfeng
Tankersley, Chris
Delarue, Richard
Co, Melannie
Trotman, Judith
BLOOD ADVANCES, 2023, 7 (22) : 6801 - 6811
[8] Systematic Literature Review of the Clinical Efficacy and Safety of Treatments in the Relapsed/Refractory Setting for Patients with Follicular Lymphoma or Marginal Zone Lymphoma
Monga, Neerav
Garside, Jamie
O'Donovan, Peter
Quigley, Joan
Padhiar, Amie
Parisi, Lori
Tapprich, Christoph
Nastoupil, Loretta
BLOOD, 2017, 130
[9] Copanlisib in patients with relapsed or refractory follicular lymphoma.
Dreyling, Martin H.
Santoro, Armando
Leppa, Sirpa
Demeter, Judit
Follows, George
Lenz, Georg
Kim, Won Seog
Mollica, Luigina
Nagler, Arnon
Diong, Colin Phipps
Provencio, Mariano
Stevens, Don A.
Trevarthen, David
Magagnoli, Massimo
Cupit, Lisa
Yin, Shuxin
Hiemeyer, Florian
-Vargas, Jose E. Garcia
Childs, Barrett H.
Zinzani, Pier Luigi
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[10] EFFICACY AND SAFETY OF COPANLISIB IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: A SUBSET ANALYSIS OF THE CHRONOS-1 STUDY
Zinzani, P. L.
Santoro, A.
Leppa, S.
Demeter, J.
Follows, G. A.
Lenz, G.
Kim, W. S.
Mollica, L.
Nagler, A.
Diong, C. P.
Provenciio, M.
Stevens, D. A.
Trevarthen, D.
Maagnoli, M.
Cupit, L.
Yin, S.
Hiemeyer, F.
Garcia-Vargas, J.
Childs, B. H.
Dreyling, M.
HAEMATOLOGICA, 2017, 102 : 314 - 315

← 1 2 3 4 5 →